Medical Journal Data Sharing Policies Have Evolved
New guidance aims to clarify how researchers share sensitive data to speed up the publication process.
Updated on Sept. 30, 2026 in Nutrition
Live Poll
Should medical researchers be required to share their underlying data publicly to improve scientific transparency?
The STM organization has released voluntary recommendations to standardize medical and health data sharing policies across scientific journals. These new guidelines are designed to address researcher confusion and reduce publication delays caused by inconsistent requirements.
Why it matters
Researchers have long struggled with vague data sharing mandates that created unnecessary administrative burdens. By adopting these new best practices, journals hope to create a more efficient and transparent submission process for the global scientific community.
The new guidelines were developed by a Task-and-Finish group following a 2023 Open Pharma survey that revealed a lack of specificity in existing data sharing policies. This effort, which incorporated input from two industry workshops, replaces vague standards with concrete definitions and examples.
The players
STM
An international trade association that provides guidance and standards for academic and professional publishers.
Taylor & Francis
A major academic publisher that participated in the Task-and-Finish group to develop these data sharing standards.
OUP
The Oxford University Press, which contributed to the development of the new medical data sharing guidelines.
The details
The guidance provides a structured framework for journals to define research data, manage sensitive data exceptions, and select appropriate repositories for archiving. By incorporating specific headings and best-practice examples, the document helps publishers update their web resources to be more actionable for researchers. This approach seeks to resolve the inconsistent requirements that have historically caused delays for scientists submitting their work.
Timeline
2013: Data sharing policies began to increase across medical journals.
2023: Open Pharma conducted a survey highlighting the need for specific policy guidance.
September 2026: STM released the new voluntary data sharing recommendations.
October 6, 2026: The RDA conference is scheduled to take place in London.
Health Landscape
This release marks a significant departure from the fragmented landscape of medical publishing where individual journal requirements often lacked alignment. It follows the 2023 Open Pharma survey, providing the standardization necessary to support the broader movement toward open and reproducible science.
These policy changes primarily impact how medical researchers manage and submit their findings, which indirectly supports the integrity of the health data you rely on. While this change is administrative, it is worth noting if you are participating in clinical studies, as clearer data policies may eventually affect how your personal research information is handled.
The takeaway
Standardized data sharing policies aim to make medical research more transparent and efficient by removing inconsistencies that currently delay publication. Readers should watch for more journals to adopt these clear standards, as it strengthens the reliability of the evidence base used in patient care.
Further reading
For more on how evolving research standards influence clinical practice, explore our resources on Nutrition.
Source note: This article includes information reported by The Scholarly Kitchen.
Live Poll
Should medical researchers be required to share their underlying data publicly to improve scientific transparency?
